gepotidacin: Clinical Trials

5 completed. 5 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	5	Completed 5

Follow gepotidacin: new trials by email Literature Review of gepotidacin trials Research Report on gepotidacin

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis) Gepotidacin - Urinary Tract Infections	Phase 3	Completed	GlaxoSmithKline	97	2024-10-02	2026-02-11
A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis) Gepotidacin, Nitrofurantoin, Placebo - Urinary Tract Infections	Phase 3	Completed	GlaxoSmithKline	380	2023-01-11	2025-03-17
Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI) Gepotidacin, Placebo matching nitrofurantoin, Nitrofurantoin - Urinary Tract Infections	Phase 3	Completed	GlaxoSmithKline	1606	2020-04-23	2023-07-18
A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Gepotidacin, Ceftriaxone, Azithromycin - Gonorrhea	Phase 3	Completed	GlaxoSmithKline	628	2019-10-21	2024-05-30
A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI) Gepotidacin, Placebo matching nitrofurantoin, Nitrofurantoin - Urinary Tract Infections	Phase 3	Completed	GlaxoSmithKline	1531	2019-10-17	2023-06-22

Conditions studied

Urinary Tract Infections (4)  ·  Gonorrhea (1)

Sponsors

GlaxoSmithKline (5)

Countries

United States (4)  ·  Australia (2)  ·  Bulgaria (2)  ·  Germany (2)  ·  India (2)  ·  Mexico (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Czechia (1)  ·  Greece (1)  ·  Hungary (1)  ·  Japan (1)  ·  Poland (1)  ·  Romania (1)  ·  Slovakia (1)

Results publications

PMID 36255258, PMID 34978887, PMID 36271314, PMID 38342126, PMID 40372095, PMID 40924001, PMID 40924012, PMID 41399629, PMID 41495938, PMID 42682990, PMID 37751016, PMID 40245902, PMID 42809288, PMID 42841733

NIH funding

2018 (2)